GL1X · GenesisL1 explorer

Research workbench

HIV protease, pseudo-symmetric inhibitors

Analyse HIV protease, pseudo-symmetric inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GGX
Type
protein
Length
792 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
V-1 protease
UniProt
Q9Q2G8
Ligands
GGX
Pockets
7 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, F, G, HV-1 proteaseprotein997% helix, 54% strandQ9Q2G8

Ligands and binding sites

  • GGX · methyl [(1S)-1-{[(1R,3S,4S)-4-{[(2S)-3,3-dimethyl-2-{3-[(6-methylpyridin-2-yl)methyl]-2-oxo-2,3-dihydro-1H-imidazol-1-yl}butanoyl]amino}-3-hydroxy-5-phenyl-1-(4-pyridin-2-ylbenzyl)pentyl]carbamoyl}-2,2-dimethylpropyl]carbamate · ligand · 4 copies · chains G, H, A, B, C, E, F, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.730.8144GGX
25170.710.8050GGX
34300.690.8135GGX
44010.690.8133GGX
52280.530.7726empty

Interfaces

11 interfaces between chains.

  • A–B · 1837 Ų buried · 32 hydrogen bonds · protein-protein
  • E–F · 1828 Ų buried · 42 hydrogen bonds · protein-protein
  • C–D · 1828 Ų buried · 45 hydrogen bonds · protein-protein
  • G–H · 1811 Ų buried · 37 hydrogen bonds · protein-protein
  • B–C · 513 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 3GGX · HIV Protease, pseudo-symmetric inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.